Inflammation and Cancer: Critical View

• T.G. Shrihari

  Department of Oral Medicine and Oncology, Krishna Devaraya College of Dental Sciences and Hospital, Bangalore -562157, Karnataka, India

Inflammation is the physiological response to an injury, it could be chemical, thermal, physical and infectious for reparative activity to injury. Recent data suggest that chronic inflammation leads to cancer development. Inflammatory mediators released to surrounding environment due to inflammation by inflammatory cells acts as a defensive or offensive depends on secretion of chemical mediators of inflammation such as growth factors, cytokines activating various transcriptional pathways bring about cell proliferation, angiogenesis further leads to tumor growth. This article describe the role of inflammatory cells and its mediators to development of cancer, various underlying unanswered future challenge questions in association with inflammation and cancer.

Grivennikov SI, Greten FR, Michael K. Immunity, inflammation and cancer. Cell 2010; 140: 883-99. https://doi.org/10.1016/j.cell.2010.01.025

Shabnam S, Michael K. Immunity, inflammation, and cancer: an eternal fight between good and evil. The Journal of Clinical Investigation 2015; 125: 3347-55. https://doi.org/10.1172/JCI80007

Thiago TM, Ivan CM, Olivier H. The role of mast cells in cancers. F1000 prime Rep 2015; 7: 9.

Shrihari TG. Dual role of inflammatory mediators in cancer. E Cancer Medical Science 2017; 11: 721. https://doi.org/10.3332/ecancer.2017.721

Korniluk A, Koper O, Kemona H, Dymicka-piekarska V. From inflammation to cancer. Ir J Med Sci 2016; 2: 1-6.

Paola A, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Experimental Cell Research 2011; 317: 664-73. https://doi.org/10.1016/j.yexcr.2010.11.013

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30: 1073-81. https://doi.org/10.1093/carcin/bgp127

Chai EZP, Siveen KS, Muthu K, Shanmugam, Arfuso F, Gautamsethi. Analysis of the intricate relationship between chronic inflammation and cancer. Biochemical Journal 2015; 1: 1-15. https://doi.org/10.1042/BJ20141337

Katoh H, Watanabe M. Myeloid –derived suppressor cells and therapeutic strategies in cancer. Mediators of Inflammation 2015; 8: 1-12. https://doi.org/10.1155/2015/159269

Noy R, Pollard JW. Tumor associated macrophages: From mechanisms to therapy. Immunity 2014; 41: 49-61. https://doi.org/10.1016/j.immuni.2014.06.010

Candido J. Cancer-related inflammation. Journal of Clinical Immunology 2013; 33: 579-84. https://doi.org/10.1007/s10875-012-9847-0

Oian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39-51. https://doi.org/10.1016/j.cell.2010.03.014

Katoh H, Watanabe M. Myeloid –derived suppressor cells and therapeutic strategies in cancer. Mediators of Inflammation 2015; 8: 1-12. https://doi.org/10.1155/2015/159269

Chai EZ, Siveen KS, Shanmugam MK, Arfuso F, Sethi G. Analysis of the intricate relationship between chronic inflammation and cancer. Biochemical Journal 2015; 468: 1-15. https://doi.org/10.1042/BJ20141337

Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-44. https://doi.org/10.1038/nature07205

Okada F. Inflammation related carcinogenesis: current findings epidemiological trends. Yonago Acta Medica 2014; 57: 65-72.

Ohnishi S, Ma N, Thanam R, Pinlaor S, Hammam O, Murata M, Kawanishi S. DNA damage in inflammation related carcinogenesis and cancer stem cells. Oxidative Medicine and Cellular Longevity 2013; 43: 1-9. https://doi.org/10.1155/2013/387014

Diakos CI, Charles CA, Mcmillan DC, Clarke SJ. Cancer related inflammation and treatment effectives. The Lancet Oncology 2014; 15: 493-503. https://doi.org/10.1016/S1470-2045(14)70263-3

Balkwill FR, Mantovani A. Cancer related inflammation: common themes and therapeutic opportunities. Seminars in Cancer Biology 2012; 22: 33-40. https://doi.org/10.1016/j.semcancer.2011.12.005

Glauben L, Marjorie De La Fuente PT, Chanitra T, Marcela AH. Chronic inflammation and cytokines in the tumor microenvironment. Journal of Immunology Research 2014; 3: 1-19.

Douglas M, Gabrilovich DI. Myeloid – derived suppressor cells in tumor microenvironment: Expect the unexpected. Journal of Clin Invest 2015; 125: 3356-64. https://doi.org/10.1172/JCI80005

Condamine T, Gabrilovich DI. Can the suppressive activity of myeloid –derived suppressor cells be “chop”ped. Immunity 2014; 41(3): 341-342. https://doi.org/10.1016/j.immuni.2014.08.016

Shrihari TG. Inflammation related cancer- Highlights. J Carcinog Mutagen 2016; 7: 269.

Chen L, et al. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun 2014; 5: 5241. https://doi.org/10.1038/ncomms6241

Blankenstein T, Coulie PG, Gilboa E, Jaffee EM. The determinants of tumour immunogenicity. Nat Rev Cancer 2012; 12(4): 307-313. https://doi.org/10.1038/nrc3246

Spranger S, et al. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci Transl Med 2013; 5(200): 200ra116. https://doi.org/10.1126/scitranslmed.3006504

Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol 2015; 15(2): 73-86. https://doi.org/10.1038/nri3789

Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tegaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep 2012; 32(1): 1-15. https://doi.org/10.1042/BSR20100136

Shrihari TG. Inflammation –related cancer or cancer-related inflammation. The European Research Journal 2017; 2: 1-5. (Early online).

• PDF